Mass spectrometry (MS)-based proteomics have been increasingly implemented in various
disciplines of laboratory medicine to identify and quantify biomolecules in a variety of …

Introduction: Numerous diseases are caused by changes in post-translational modifications
(PTMs). Therefore, the number of clinical proteomics studies that include the analysis of …

Despite the high global prevalence of dry eye syndrome (DES), the fundamental processes
underlying this pathology remain largely unexplored. Therefore, this study endeavoured to …

Precision medicine as a framework for disease diagnosis, treatment, and prevention at the
molecular level has entered clinical practice. From the start, genetics has been an …

The growing availability of biomarker panels for molecular diagnostics is leading to an
increasing need for fast and sensitive biosensing technologies that are applicable to point-of …

There is a critical need for the discovery of novel biomarkers for early detection and targeted
therapy of cancer, a major cause of deaths worldwide. In this respect, proteomic …

Recent technological advancements in mass spectrometry (MS)‐based proteomics
technologies have accelerated its application to study greater and greater numbers of …

There is a high demand for a non-invasive, rapid, and highly accurate tool for disease
diagnostics. Recently, saliva based diagnostics for the detection of specific biomarkers has …

Proteomics have passed through a tremendous development in the recent years by the
development of ever more sensitive, fast and precise mass spectrometry methods. The …

Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide. Biomarkers
that can facilitate better clinical management of CRC are in high demand to improve patient …